ASAM Pocket Guidelines and Patient Guide

Benzodiazepine Tapering

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1532950

Contents of this Issue

Navigation

Page 20 of 29

21 Onset of action (min) b Elimination half-life (h) c Metabolism d 15–30 6–12 CYP3A4 15–30 5–10 36–200 (AM) CYP3A4 15–30 18–50 CYP3A4 15 CYP2C19 CYP3A4 ≤15 20–100 36–200 (AM) CYP1A2 CYP2C9 CYP2C19 CYP3A4 30–60 10–24 CYP3A4 ≤15 40–250 (AM) CYP2C19 CYP3A4 15–30 10–20 Glucuronide conjugation 30–60 4–15 Glucuronide conjugation 15 39 73 (AM) CYP2C9 CYP2C19 CYP3A4 30–60 10–20 Glucuronide conjugation 15–30 1.5–5 CYP3A4

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Benzodiazepine Tapering